EPISODE · Feb 11, 2026 · 1 MIN
Ultra-High-Dose Methylcobalamin: Safety in ALS Patients
from TheBrief.Health · host TheBrief.Health
Ultra-high dose methylcobalamin is being studied as a potential ALS therapy, offering hope for slowing disease progression and expanding treatment options for patients and families.
What this episode covers
Ultra-high dose methylcobalamin is being studied as a potential ALS therapy, offering hope for slowing disease progression and expanding treatment options for patients and families.
NOW PLAYING
Ultra-High-Dose Methylcobalamin: Safety in ALS Patients
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m